Actively Recruiting

Phase 3
Age: 18Years - 65Years
All Genders
NCT06963034

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Led by Neurocrine Biosciences · Updated on 2026-03-06

284

Participants Needed

21

Research Sites

125 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.

CONDITIONS

Official Title

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant has a primary diagnosis of schizophrenia
  • Participant is experiencing an acute exacerbation or relapse of symptoms and currently warrants hospitalization
  • Participants taking prohibited medications, including antipsychotics, must discontinue before study participation
  • Participant is willing and able to remain in an inpatient setting for the study duration, follow instructions, and comply with the protocol requirements
Not Eligible

You will not qualify if you...

  • Participant has known hypersensitivity to any component of the formulation of NBI-1117568
  • Participant has an unstable or poorly controlled medical condition or chronic disease
  • Participant is considered by the investigator to be at imminent risk of suicide or injury to self or others
  • Participant has a diagnosis of moderate or severe substance use disorder (except nicotine or caffeine dependence) within 6 months prior to screening
  • Participant has a positive alcohol test or drug screen for disallowed substances
  • Participant has a history of poor or suspected poor compliance in clinical research studies or is judged unable to adhere to protocol requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 21 locations

1

Neurocrine Clinical Site

Bryant, Arkansas, United States, 72022

Actively Recruiting

2

Neurocrine Clinical Site

Little Rock, Arkansas, United States, 72211

Actively Recruiting

3

Neurocrine Clinical Site

Anaheim, California, United States, 92805

Actively Recruiting

4

Neurocrine Clinical Site

Pico Rivera, California, United States, 90660

Actively Recruiting

5

Neurocrine Clinical Site

San Diego, California, United States, 92123

Actively Recruiting

6

Neurocrine Clinical Site

Sherman Oaks, California, United States, 91403

Actively Recruiting

7

Neurocrine Clinical Site

Torrance, California, United States, 90504

Actively Recruiting

8

Neurocrine Clinical Site

Hollywood, Florida, United States, 33024

Actively Recruiting

9

Neurocrine Clinical Site

Miami Lakes, Florida, United States, 33016

Actively Recruiting

10

Neurocrine Clinical Site

Atlanta, Georgia, United States, 30331

Actively Recruiting

11

Neurocrine Clinical Site

Decatur, Georgia, United States, 30030

Actively Recruiting

12

Neurocrine Clinical Site

Snellville, Georgia, United States, 30078

Actively Recruiting

13

Neurocrine Clinical Site

Chicago, Illinois, United States, 60640

Actively Recruiting

14

Neurocrine Clinical Site

Gaithersburg, Maryland, United States, 20877

Actively Recruiting

15

Neurocrine Clinical Site

Watertown, Massachusetts, United States, 02472

Actively Recruiting

16

Neurocrine Clinical Site

Marlton, New Jersey, United States, 08053

Actively Recruiting

17

Neurocrine Clinical Site

Staten Island, New York, United States, 10314

Actively Recruiting

18

Neurocrine Clinical Site

The Bronx, New York, United States, 10461

Actively Recruiting

19

Neurocrine Clinical Site

Austin, Texas, United States, 78754

Actively Recruiting

20

Neurocrine Clinical Site

DeSoto, Texas, United States, 75115

Actively Recruiting

21

Neurocrine Clinical Site

Houston, Texas, United States, 77043

Actively Recruiting

Loading map...

Research Team

N

Neurocrine Medical Information Call Center

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here